Jane C. Andrews, Ph.D., Founder & CEO
Dr. Andrews is a recognized leader in Life Sciences, Regenerative Medicine and Cell Therapy, with a deep understanding of the technology, markets and operational aspects of these industries, and how they will grow for biomedical advancement. The Cell Bridge Strategies team, under Jane's leadership, helps companies match their strengths with market opportunities by bridging the gap between Science and Business. This often involves helping companies with targeting their key assets, creating strategies, executing on tactics, building financial and market models, and in many cases, identifying potential partnerships, funding and/or M&A assessments. New advisory boards are often created to provide additional corporate (client) guidance. Dr. Andrews has built a global network of Life Science and Regenerative Medicine experts that can be tapped into to aid Cell Bridge Strategies clients. Read more
Neil Kellen, Principal Consultant – Strategy and Finance & CFO
Mr. Kellen is a senior level executive with extensive hands-on experience in all aspects of business management, leadership, M&A, board relations, investor relations, bank relations, legal, manufacturing, sales channels, and more. He provides financial and strategic analysis and financial projections for companies in the Life Sciences Space. He assists clients in positioning for partnerships, acquisition and/or IPO; projections for assessing new product introduction options using combine market and financial modeling; and developing multi-year pricing strategies to balance market penetration, profitability and competition. Let's meet. Click here to schedule a call.
Keith Parent, Advisor & Principal Consultant
Keith Parent has built a reputation as a leader in the development and support of IT systems for pharmaceutical, biotech and medical device companies. With over 35 years of technology and leadership experience in the Life Science industry, Keith has a clear understanding of regulatory challenges and the Good System Practices (GSPs) required to maintain a Qualified state for the company’s clients.
Keith holds a Master of Science in Computer Science (MSCS) from Rensselaer Polytechnic Institute and a Bachelor of Science in Computer Science from Siena College. Keith has been involved in the implementation and maintenance of enterprise-level systems across pre-clinical and clinical organizations of numerous Life Science clients. He has been responsible for the management of over 5,000 servers world-wide for Life Science clients, including CTMS, Global Submission, eCTD systems, FDA Gateways, Adverse Event Reporting systems, as well as numerous Clinical Trial and Longitudinal Patient Registries, with responsibility for over 100,000+ users in various clinical settings. Keith has been a consultant to Pfizer Pharmaceutical for over 27 years and numerous other Life Science leadership positions. He is a regular guest speaker at major Life Science events and a thought leader for companies building solutions in this space. Let's meet. Click here to schedule a call.
Preveen Ramamoorthy, Ph.D., Advisory Board Member & Principal Consultant
Dr. Ramamoorthy is a leader in Global Precision Medicine - Cell & Gene Therapy, Biologics, Biomarkers, Diagnostics and Medical Devices. He is a clinician by wiring and a biologist by training. He is a passionate, patient centric-innovator, global executive, entrepreneur, and academician with 15+ years of experience. His in-depth and breadth of people, product and process leadership experience spans Biologics Development (Vaccines, MAbs), Precision Medicine Diagnostics (Genomics, Proteomics, Immunoassays, Multi-Omics Biomarkers) and Medical Devices (Blood Transfusion, Immunotherapy, Stem Cell Therapy, Cell & Gene Therapy, CAR-T Cell Therapy). Specialties include: R&D/Innovation Leadership, Pre-clinical & Clinical Development, Global Lab & Clinical Operations, Data Analytics (Bioinformatics & AI), Therapeutic Experience (Oncology, Immune Diseases, Rare Diseases, Infectious Diseases), customer intimacy, Rapid Ideation to Revenue Impact, Strategic Scientific & Clinical Collaboration, Market Intelligence. He has held numerous positions including: President, Clinical Diagnostics and Head of R&D for Healthtell/Icarbonx; Vice President, Global Scientific & Clinical Affairs for Terumo BCT, and Head of Diagnostics & Vice President of Clinical Diagnostics, Strand Life Sciences. Let's meet. Click here to schedule a call.
Michael J. Fiske M.S. Principal Consultant
Michael is a highly motivated scientist and executive with significant experience in early phase development of protein and cell therapy products and proven success from candidate discovery, characterization, and process development, through clinical-scale GMP production and testing. His technical background and experience span a wide range of biotechnology products including the Advanced Cellular Therapies, industrial enzymes, metabolic pathway intermediates, diagnostics, vaccines, and therapeutic proteins.
Mike Fiske is Vice President of Manufacturing Sciences at Scorpion Biological Services, which operates a multi-use, cGMP-compliant, contract manufacturing facility designed for the development and manufacture of advanced therapies. He has more than 30 years in the biotechnology industry as a protein chemist, analytical biochemist, process development scientist and cGMP operations manager.
Michael’s skills include new facility design, construction and validation, technology transfer, process and analytical methods development, cGMP manufacturing as well as characterization and QC release testing of preclinical and clinical grade advanced therapy biologic products. He also helps clients with preparation of regulatory documents and interactions with regulatory agencies.
Education: MS, Biochemistry, SUNY Binghamton.
Rick Stockton, Principal Consultant
Rick is also Designer and Principal at J. R. Stockton Consulting, LLC. Rick’s background in process engineering, manufacturing, and device design makes him an ideal fit for Cell Bridge Strategies clients, that are undergoing facility and new product design and/or scale-up. His innate conceptual abilities allow him to visualize the process and task at hand and create the best three-dimensional solutions for buildout, equipment design and validation. He is an expert at product and system development, from a conceptual and mechanical perspective. He routinely works on process, manufacturing, product development, ideation, invention and complete product and system design at the corporate level.
His typical work is to take an existing concept or desire and compliment it with the things that will make it practical to produce, deploy and maintain a) Concepts become working prototypes ready to be validated; b) Prototypes become reliable, affordable, rapidly manufactured products; c) Design’s interface between products and those who use them; d) Design systems utilize the products, including human interfaces, machine interfaces, and facility layouts. Let's meet. Click here to schedule a call.
Beth Roxland, JD, MA Bioethics & Principal Consultant
Dr. Roxland is also Founder of Roxland Consultants, LDT. She is an expert in Life Science, Strategic Law in Healthcare, Medicine & Science Research. Her skills include legal aspects of regulatory rules, trends in the pharmaceutical, biologics and medical device areas. She uses real-world evidence and big data; develops internal policies and standards for early phase testing and clinical trial design and has worked for clients in areas ranging from new health technology and apps; drug pricing; clinical trial oversight; privacy; data transparency and patient engagement. Dr. Roxland has held numerous positions including Bioethics and Strategy Leader, Office of the Chief Medical Officer - Johnson & Johnson; Adjunct Professor of Law - New Your University, School of Law, New York, NY; Executive Director, New York Task Force on Life and the Law & Special Advisor to the Commissioner of Health on Stem Cell Research Ethics, NYSTEM and the NYS Stem Cell Research Board's Ethics Committee. She received her Juris Doctorate and Masters in Bioethics at the University of Pennsylvania Law School, University of Pennsylvania. Let's meet. Click here to schedule a call.
Jan Rodriguez, RN, CCRA, Senior Consultant
Jan Rodriguez is a Registered Nurse, CCRA and an expert at managing and monitoring international and national Clinical Trials ranging from Phase I- IV for drugs, medical devices and biologics. Ms. Rodriguez's 20 years of experience includes clinical monitoring, project management, regulatory, contract negotiations, study start up, SAE reporting/reconciliation and development of study specific tools. Her therapeutic areas of experience include hematology/oncology, analgesia, cardiology, CNS, diabetes, endocrinology, gene therapeutics, infectious disease, pediatrics, orthopedic/skeletal diseases and medical devices. Let's meet. Click here to schedule a call.
We are senior-level executives who have extensive hands-on experience in all aspects of business management, leadership, M&A, working with Board of Directors, Attorneys, banks, strategic partners, and customers.
Our talent pool includes experienced medical professionals, scientists, legal professionals, CEO, COOs, and CFOs who can add senior leadership and guidance to get you to the next step.